1-4 of 4
Dima Yackoubov
Close
Sort by
Journal Articles

Transcriptional and Metabolic Profiling of Nicotinamide-Enhanced Natural Killer (NAM-NK) Cells (GDA-201)

Dima Yackoubov, Aviad Pato, Julia Rifman, Sherri Cohen, Astar Hailu, Nurit Persi, Orit Berhani-Zipori, Avishai Edri, Boaz Buhandler, Moshe Shahor, Nathan Dinowitz, Amram Ben David, Avi Izraeli, Vered Caspi, Liron Levin, Amnon Peled, Frank Cichocki, Joshua Rabinowitz, Wenyun Lu, Melanie McReynolds, Tracey Lodie, Julian Adams, Ronit Simantov, Yona Geffen
Journal: Blood
Blood (2021) 138 (Supplement 1): 4791.
https://doi.org/10.1182/blood-2021-149468
Published: 2021
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Is Associated with Robust Immune Reconstitution and Lower Rates of Severe Infection Compared to Standard Umbilical Cord Blood Transplantation

Paul Szabolcs, Stuart Levy, Dima Yackoubov, Aviad Pato, Einat Galamidi-Cohen, Mitchell E. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 333.
https://doi.org/10.1182/blood-2021-153408
Published: 2021
Journal Articles

Nicotinamide (NAM) Modulates Transcriptional Signature of Ex Vivo Cultured UCB CD34+ Cells (Omidubicel) and Preserves Their Stemness and Engraftment Potential

Tracey Lodie, PhD, Julian Adams, PhD, Dima Yackoubov, Msc, Yair Steinhardt, MSc, Dorit Ashengrau, Adi Bitansky, Alina Maliutina, Sherry Cohen, Boaz Buhenvald, PhD, Moshe Shahor, PhD, Nathan Dinowitz, PhD, Vered Caspi, PhD, Amnon Peled, PhD, Tony Peled, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3718.
https://doi.org/10.1182/blood-2019-131124
Published: 2019
Journal Articles

Nicotinamide, a Recognized Inhibitor of SIRT1, Promotes Expansion in Ex Vivo Cultures of Short and Long-Term Repopulating Cells.

Tony Peled, Hadas Shoham, Dorit Aschengrau, Dima Yackoubov, Gabi Frei, Arnon Nagler, Katia Beider, Amnon Peled
Journal: Blood
Blood (2009) 114 (22): 2431.
https://doi.org/10.1182/blood.V114.22.2431.2431
Published: 2009